ReviewDiabetes, obesity & metabolism2026
Cardiovascular-Kidney-Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling.
Review in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiovascular-Kidney-Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling.Diabetes, obesity & metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimsCardiovascular-kidney-metabolic (CKM) syndrome has developed into a global public health crisis. Although integrated care is increasingly used to treat patients with CKM, current health economic models fail to capture the value of considering the CKM syndrome as a unified condition. We present a conceptual framework to guide development of a new health economic model that captures value holistically across interconnected CKM domains. MATERIALS AND
methodsFollowing best-practice guidelines, we undertook a review of published literature to identify and connect the key biological drivers of the CKM syndrome. These insights were synthesised into a biological framework, which was simplified into a streamlined influence diagram of sufficient complexity to guide model development. Both framework and diagram were iteratively reviewed and developed based on feedback from clinicians, health economists and modelling specialists.
resultsA biological framework and influence diagram were developed to illustrate how the CKM syndrome's biological drivers interconnect and link to key clinical outcomes. We detail the components of these diagrams, explaining the rationale behind connections. We discuss how the proposed framework could inform a model for future health economic evaluation.
conclusionThere is a clear unmet need for comprehensive modelling of the CKM syndrome to support evidence-based decision-making and guide management of this highly prevalent, far-reaching disease. As more evidence has become available, the mathematical development, in the near future, of a long-term, holistic and flexible health economic model has become feasible, despite some gaps. This work seeks to shape a shared understanding of the challenges and opportunities in this developing field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.